Entia Biosciences Inc unveils ErgoD2 Flex-RA medical food for Rheumatoid Arthritis.
M2 EQUITYBITES-May 3, 2012-Entia Biosciences Inc unveils ErgoD2 Flex-RA medical food for Rheumatoid Arthritis(C)2012 M2 COMMUNICATIONS http://www.m2.com
Food science company Entia Biosciences Inc (ERGO.OB) (ENTIA) reported on Wednesday the launch of a new medical food, called ErgoD2 Flex-RA, for the treatment of Rheumatoid Arthritis (RA).
Rheumatoid Arthritis (RA) is a systemic autoimmune disease that causes pain, stiffness, swelling and loss of function in the joints.
The company added that ErgoD2 Flex-RA is an encapsulated medical food product with active anti-inflammatory bionutrients formulated to improve immune function, control joint inflammation and potentially mediate systemic and local RA symptoms.
According to a study presented at the 2008 European Union League Against Rheumatism (EULAR) meeting in Paris, nearly 75% of patients, including those who were subsequently diagnosed with inflammatory joint diseases, soft-tissue rheumatism, uncomplicated musculoskeletal backache or osteoporosis, were deficient in vitamin D.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||May 3, 2012|
|Previous Article:||USANA Health Sciences Inc names female entrepreneur Jen Groover as company spokesperson.|
|Next Article:||EVERTEC and EVERTEC Finance Corp price offering of USD40m Senior Notes due 2018.|